H.Con.Res.53 is a concurrent resolution that recognizes September 26, 2025, as World Contraception Day and expresses the sense of Congress on expanding access to contraception both in the United States and abroad. The text collects public-health findings—ranging from historical abuses to the public‑health and economic benefits of contraception—and asks federal policymakers to pursue measures to increase affordable, high‑quality access.
Although the resolution is nonbinding, it is detailed: it asks Congress and the executive branch to study contraceptive deserts, expand provider training, support coverage (including over‑the‑counter methods), align legal definitions with FDA/WHO standards, and prioritize equity for communities affected by medical racism and socioeconomic barriers. The document names specific federal programs and types of action it wants prioritized, making it a compact statement of legislative priorities for agencies and appropriators to consider.
At a Glance
What It Does
The resolution expresses the House’s sense that federal lawmakers and the executive branch should expand universal, affordable contraception access, support related domestic and foreign programs, promote training for providers, and enable over‑the‑counter availability and coverage. It also codifies a broad, science‑aligned definition of contraception that incorporates current and future FDA‑approved methods and the World Health Organization’s list of methods.
Who It Affects
The resolution signals priorities for federal departments and programs (HHS agencies, FDA, CMS, USAID), federally funded family planning providers, insurance programs, and health care workforces—especially primary care clinicians asked to provide reversible methods. It also speaks to state policymakers, pharmacies, and payers that influence access on the ground.
Why It Matters
By mapping a policy agenda—coverage without cost sharing, training, OTC access, program funding, and an explicit equity focus—the resolution frames the federal conversation on contraception access. It is a policy blueprint that agencies and appropriators can reference even though it does not itself create legal obligations or funding authorizations.
More articles like this one.
A weekly email with all the latest developments on this topic.
What This Bill Actually Does
The resolution opens with a set of findings: it situates contraception access as a recognized public‑health achievement and a component of the United Nations’ Sustainable Development Goals; it cites clinical and population benefits such as reductions in unintended pregnancy, unsafe abortion, and maternal mortality; and it highlights economic, educational, and mental‑health benefits tied to access. The text explicitly acknowledges a history of coercion and medical abuses against Native people, people of color, immigrants, and people with disabilities—framing access efforts as needing to address mistrust and past harms.
The bill documents current access barriers: a large unmet global need for modern contraception, U.S. shortages described as “contraceptive deserts,” workforce gaps (including many counties without an OB‑GYN), state‑level refusal and restriction regimes for contraception and emergency contraception, and affordability problems even where methods are available. It also notes the July 2024 FDA approval that enabled a progestin‑only pill to move OTC in the United States and cites survey evidence about consumer interest tied to cost savings.Instead of commanding agencies, the resolution lays out thirteen “sense of Congress” directives.
Those directives ask Congress and the executive branch to promote universal, affordable access (including coverage without cost sharing), expand training so primary care clinicians can provide highly effective reversible methods, study contraceptive deserts and innovations, align legal and policy definitions with scientific authorities, address disparities across race, disability, immigration status, gender identity, and sexual orientation, and ensure that U.S. domestic and foreign assistance programs support contraception, safe abortion services, and postabortion care.Operationally, the text names the categories of federal programs it wants protected or expanded—programs that are already central to family planning delivery—and clarifies that by “contraception” it intends the full range of current and future FDA‑approved methods plus the WHO’s enumerated modern methods. The resolution’s mix of findings and directive language is intended to shape legislative priorities, regulatory attention, and funding debates without creating new statutory duties or appropriation authority.
The Five Things You Need to Know
The resolution explicitly asks both Congress and the President’s administration to ensure universal, expansive access to free or affordable contraception (Sense clause 1).
It directs federal policymakers to ensure insurance coverage that includes contraception without prescription or cost sharing and to include abortion in consistent reproductive‑health coverage (Sense clause 4).
The text defines “contraception” to include all present and future FDA‑approved, cleared, or granted methods and enumerates WHO‑style methods (sterilization, IUD, implant, injectables, pills, condoms, diaphragms, lactational amenorrhea, emergency contraception, etc.) (Sense clause 6).
The resolution tells Congress and the administration to protect and increase support for specific domestic and foreign family‑planning delivery mechanisms—naming programs such as Title X, Medicaid, the Indian Health Service, TRICARE, certain 638 clinics, Federal health providers, and USAID’s Office of Population and Reproductive Health (Sense clauses 11–12).
It calls for concrete study and operational work: examining contraceptive deserts, pursuing evidence‑based innovations, and expanding training in counseling, provision, and follow‑up care so primary‑care clinicians can offer highly effective reversible contraception (Sense clauses 3 and 5).
Section-by-Section Breakdown
Every bill we cover gets an analysis of its key sections.
Findings: public‑health case, historical harms, and access barriers
The preamble assembles epidemiological and social‑science evidence to justify action: it cites the CDC’s recognition of family planning as a major public‑health achievement, the UN SDG target on sexual and reproductive health, and population estimates about prevented unintended pregnancies and maternal deaths. The recitals also catalogue present barriers—contraceptive deserts, provider shortages, state refusal laws, and affordability problems—and explicitly recount historic coercion and medical experimentation against marginalized groups. Those findings set the normative frame the rest of the resolution builds on and are intended to buttress the subsequent policy asks by tying them to public‑health and human‑rights rationales.
Statement of priority and calls to study access gaps
Clauses 1–3 form the resolution’s opening asks: they urge federal leaders to prioritize universal, affordable access and to treat bodily autonomy and medically accurate information as central goals. Clause 3 specifically asks Congress and the administration to study contraceptive deserts, evidence‑based methods, and potential federal policy responses. Practically, these clauses function as an explicit research and agenda‑setting request that congressional committees and executive agencies could lean on when proposing legislation, drafting regulatory guidance, or announcing grant solicitations.
Coverage, comprehensive reproductive‑health access, and a science‑aligned definition
Clauses 4 and 6 move from principle to definitional and coverage priorities. Clause 4 asks for consistent, affordable insurance coverage for reproductive health needs, explicitly referencing contraception without prescription or cost sharing and including abortion. Clause 6 adopts an expansive, future‑proof definition of contraception tied to FDA status and WHO categories. Those two clauses together create a framework: if implemented, federal regulators and payers would be urged to treat OTC status and new FDA approvals as within the expected coverage universe and to interpret ‘contraception’ broadly for policy design and program rules.
Workforce and education: training and sex‑education priorities
Clause 5 focuses on expanding training so primary‑care clinicians can counsel, provide, and follow up for highly effective reversible contraception; clause 10 asks for expanded, gender‑inclusive sex education and patient‑centered counseling. Together these asks point to workforce development, medical‑education curricula, and K–12 or community education policy levers. For program managers, the implication is a push to fund training grants, update clinical guidance, and incorporate contraceptive counseling into broader public‑health education efforts.
Domestic and foreign assistance, program protections, and OTC access
Clauses 11–12 request that U.S. foreign assistance and domestic programs support contraception, safe abortion services, and postabortion care and explicitly call out a set of programs—Title X, Medicaid, Indian Health Service/638 clinics, TRICARE, Federal providers, and USAID’s population office—for protection and funding. Clause 13 urges expanded access and coverage for OTC birth control and other contraception without prescription. These provisions map the resolution’s policy targets: appropriations and program design for domestic delivery systems, grant or contracting priorities for USAID, and payer rules that would need to be updated to accommodate OTC pathways and coverage expectations.
This bill is one of many.
Codify tracks hundreds of bills on Healthcare across all five countries.
Explore Healthcare in Codify Search →Who Benefits and Who Bears the Cost
Every bill creates winners and losers. Here's who stands to gain and who bears the cost.
Who Benefits
- People capable of pregnancy experiencing access barriers — Low‑income, rural, and young individuals could gain more affordable, proximate options if agencies follow the resolution’s calls to expand coverage, enable OTC pathways, and study contraceptive deserts. The resolution’s equity framing also targets racial and Indigenous communities that research shows face higher maternal morbidity and access obstacles.
- Primary‑care clinicians and health centers — The push to expand training and broaden who provides highly effective reversible methods would create opportunities (and potential reimbursements) for community health centers and primary‑care practices to offer a fuller contraceptive mix locally.
- Global health programs and recipient populations — By urging that U.S. foreign assistance include contraception, safe abortion services, and postabortion care, the resolution signals support for international family‑planning programs and the populations they serve, particularly in low‑ and middle‑income countries where unmet need is concentrated.
- Pharmacies and OTC manufacturers — A federal push to expand OTC access and ensure coverage increases market opportunities for manufacturers and retail pharmacies that can stock and distribute OTC contraceptives, especially if payers adapt reimbursement policies.
- Public‑health and academic researchers — The call to study deserts, innovations, and workforce gaps creates a demand signal for data collection, implementation research, and evaluation grants. This can accelerate evidence generation and program improvement.
Who Bears the Cost
- Federal agencies and program budgets — HHS components, CMS, FDA, and USAID would face policy and operational pressure to translate the resolution’s priorities into rules, guidance, research programs, or funding requests, which could require reallocated staff time and new appropriations if pursued.
- Payers and insurers — If payers are asked to cover OTC methods without cost sharing, insurers and federal programs like Medicaid must adjust benefit designs, coding, and reimbursement processes (and potentially absorb higher short‑term costs even if long‑term savings follow).
- State and local public‑health systems — Expanding training, sex education, and program coverage will require coordination and possibly new resources at the state and local level, creating budgetary and administrative burdens for underfunded health departments and school systems.
- Providers claiming conscience or religious exemptions — The resolution’s emphasis on comprehensive access and coverage increases friction with providers or institutions in jurisdictions that allow refusals for contraceptive services, potentially creating legal and policy disputes.
- Pharmaceutical supply chains and pharmacies — Ensuring consistent, affordable OTC pricing and equitable distribution may require contracting changes, subsidy programs, or market oversight that distributors and retailers must accommodate.
Key Issues
The Core Tension
The central dilemma the resolution exposes is this: policymakers want to expand universal, equitable, and affordable contraception access while simultaneously acknowledging and avoiding the coercive medical practices of the past; achieving both requires expanding services and choice without repeating historic abuses—an outcome that demands resources, nuanced program design, community trust‑building, and legal reforms that the resolution signals but does not concretely supply.
The resolution is a policy statement, not a statutory or regulatory instrument. That limits its legal force: it cannot compel agencies to change coverage rules, appropriate funds, or override state laws that restrict access.
The practical question becomes whether Congress or the administration will translate these sense clauses into binding legislation, agency rulemaking, or appropriations—each of which carries its own political and technical hurdles.
Several implementation tensions are unresolved in the text. First, advocating insurance coverage for OTC contraception raises practical questions about payment mechanisms—how payers will reimburse pharmacies for OTC products, what billing codes to use, and how to prevent cost‑shifting.
Second, the resolution’s broad definitions and calls to include abortion within consistent reproductive‑health coverage collide with existing federal and state restrictions; reconciling those differences would likely require new statutes or regulatory reinterpretations. Third, the text asks for expansive training and workforce shifts at a time when many counties lack specialists; scaling that training without dedicated funding or workforce incentives will be difficult.
Finally, the resolution recognizes historical coercion even as it urges expanded access; operationalizing both priorities—expansion and protection against coercion—requires careful community engagement, safeguards, and oversight mechanisms that the resolution does not specify.
Try it yourself.
Ask a question in plain English, or pick a topic below. Results in seconds.